Device Trial Radar · NCT03168659
CardioFocus HeartLight Post-Approval Study
Last checked: Nov 20, 2026Latest source record: Aug 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
250
Planned (sponsor's estimate)
Start
Jun 16, 2017
Primary completion
Oct 2026
Study completion Oct 2028
Sponsor
- Lead sponsor
- CardioFocusNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 30, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.
Conditions
- Atrial Fibrillation
Interventions
HeartLightDevice
HeartLight Endoscopic Ablation System
AblationProcedure
Pulmonary vein isolation ablation
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of participants free from symptomatic atrial fibrillation (AF) or symptomatic atypical atrial flutter/atrial tachycardia (AFL/AT) lasting longer than 30 seconds post the 90 day blanking periodTime frame: Day 91 through 12 months
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
University of Arizona Sarver HeartCenter
Tucson, Arizona · Recruiting
University of Illinois
Chicago, Illinois · Recruiting
Mount Sinai Hospital
New York, New York · Recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.